Literature DB >> 16634967

Myoepithelial carcinoma arising in an adenomyoepithelioma of the breast: case report with immunohistochemical and mutational analysis.

Bo Han1, Ichiro Mori, Misa Nakamura, Xiaojuan Wang, Takashi Ozaki, Yasushi Nakamura, Kennichi Kakudo.   

Abstract

Adenomyoepithelioma (AME) of the breast is an uncommon tumor characterized by biphasic proliferation of both epithelial and myoepithelial cells. In rare instances, the epithelial, the myoepithelial or both components of an AME may become malignant. Described herein is the case of a 69-year-old woman who presented with myoepithelial carcinoma of the breast in an AME. Malignancy of myoepithelial component (MEC) was evidenced by the presence of cytological atypia, high mitotic rate, necrosis and local invasion. Immunohistochemical study demonstrated strong expression of P53 and phosphorylated extracellular signal-regulated kinase 1/2 in MEC. Laser capture microdissection technique and mutational analysis further revealed point mutation of the p53 gene (T-->G transversion at codon 270) in this population, but not in glandular epithelial cells or adjacent normal ductal epithelium. No mutations in exons 1 and 2 of the K-, H-, and N-ras genes were identified in any of the neoplastic component. To the authors' knowledge this is the first report of a mutation in the p53 gene in a malignant AME of the breast.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634967     DOI: 10.1111/j.1440-1827.2006.01948.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Myoepithelial carcinoma with contralateral invasive micropapillary carcinoma of the breast.

Authors:  Sun Young Kwon; Young Kyung Bae; Jihyong Cho; Sun Hee Kang
Journal:  J Korean Surg Soc       Date:  2011-09-26

2.  Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases.

Authors:  Natalia Buza; Nazila Zekry; Colette Charpin; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2010-07-24       Impact factor: 4.064

Review 3.  Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses.

Authors:  L Cima; H Kaya; C Marchiò; R Nishimura; H Y Wen; V P Fabbri; M P Foschini
Journal:  Virchows Arch       Date:  2021-08-30       Impact factor: 4.535

4.  Lessons From Managing the Breast Malignant Adenomyoepithelioma and the Discussion on Treatment Strategy.

Authors:  Zhu Yuan; Xiang Qu; Zhong-Tao Zhang; Wen G Jiang
Journal:  World J Oncol       Date:  2017-08-27

5.  Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.

Authors:  Felipe C Geyer; Anqi Li; Anastasios D Papanastasiou; Alison Smith; Pier Selenica; Kathleen A Burke; Marcia Edelweiss; Huei-Chi Wen; Salvatore Piscuoglio; Anne M Schultheis; Luciano G Martelotto; Fresia Pareja; Rahul Kumar; Alissa Brandes; Dan Fan; Thais Basili; Arnaud Da Cruz Paula; John R Lozada; Pedro Blecua; Simone Muenst; Achim A Jungbluth; Maria P Foschini; Hannah Y Wen; Edi Brogi; Juan Palazzo; Brian P Rubin; Charlotte K Y Ng; Larry Norton; Zsuzsanna Varga; Ian O Ellis; Emad A Rakha; Sarat Chandarlapaty; Britta Weigelt; Jorge S Reis-Filho
Journal:  Nat Commun       Date:  2018-05-08       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.